Cochlear downgraded its NPAT guidance for fiscal year 2025 by about 6% to a range of AUD 390 million to AUD 400 million, driven by a larger-than-expected decline in services revenue.
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
